IP Library Granted Patent US 7,501,252
Granted Patent B2
US 7,501,252 · App. 11/768,865 · Granted Mar 10, 2009

Use of predetermined nucleotides having altered base pairing characteristics in the amplification of nucleic acid molecules

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,501,252
App. No.
11/768,865
Granted
Mar 10, 2009
Kind
B2
Abstract

The present invention provides improved methods for amplifying a nucleic acid molecule. More specifically, the invention provides methods for nucleic acid amplification which use primers having equivalent priming efficiency.

Claims (32)

1. A kit for amplifying a nucleic acid, said kit comprising a set of first and second amplification primers which exhibit a decreased difference between their Tms with respect to each other when hybridized to a template, and a DNA polymerase.

2. A method for amplifying a nucleic acid, said method comprising amplifying said nucleic acid using a set of first and second amplification primers which exhibit a decreased difference between their Tms with respect to each other when hybridized to a template.

3. An amplification mixture, said mixture comprising a set of first and second amplification primers which exhibit a decreased difference between their Tms with respect to each other when hybridized to a template, and a DNA polymerase.

4. The kit of claim 1 , wherein said primers are contained separately from each other.

5. The kit of claim 1 , wherein said DNA polymerase is contained separately from one or both of said primers.

6. The kit of claim 1 , wherein said primers have equalized Tms.

7. The kit of claim 1 , wherein one or both of said primers comprises a nucleotide having an altered base pairing characteristic.

8. The kit of claim 1 , wherein said one or both of said primers comprises a detectable label.

9. The kit of claim 8 , wherein said detectable label is selected from the group consisting of an enzymatic label, radioisotopic label, fluorescent label, chemical label, and a modified base.

10. The kit of claim 8 , wherein said detectable label is a fluorescent label.

11. The kit of claim 1 , wherein one or both of said primers comprises a poly-G, poly-A, poly-T, or poly-C sequence.

12. The method of claim 2 , wherein said primers have equalized Tms.

13. The method of claim 2 , wherein one or both of said primers comprises a nucleotide having an altered base pairing characteristic.

14. The method of claim 2 , wherein one or both of said primers comprise a detectable label.

15. The method of claim 14 , wherein said detectable label is selected from the group consisting of an enzymatic label, radioisotopic label, fluorescent label, chemical label, and modified base.

16. The method of claim 14 , wherein said detectable label is a fluorescent label.

17. The method of claim 2 , wherein one or both of said primers comprises a poly-G, poly-A, poly-T, or poly-C sequence.

18. The method of claim 2 , wherein said nucleic acid is DNA.

19. The method of claim 2 , wherein said nucleic acid is RNA.

20. The method of claim 2 , wherein said nucleic acid is polyadenylated at its 3′ end, and wherein one of said primers contains poly-T.

21. The method of claim 2 , wherein said nucleic acid, copy thereof, or complementary copy thereof has been extended to contain a 3′ sequence to which one of said primers can hybridize.

22. The mixture of claim 3 , wherein said primers have equalized Tms.

23. The mixture of claim 3 , wherein one or both of said primers comprises a nucleotide having an altered base pairing characteristic.

24. The mixture of claim 3 , wherein one or both of said primers comprises a detectable label.

25. The mixture of claim 24 , wherein said detectable label is selected from the group consisting of an enzymatic label, radioisotopic label, fluorescent label, chemical label, and modified base.

26. The mixture of claim 24 , wherein said detectable label is a fluorescent label.

27. The mixture of claim 3 , wherein one or both of said primers comprises a poly-G, poly-A, poly-T, or poly-C sequence.

28. The mixture of claim 3 , further comprising a nucleic acid template.

29. The mixture of claim 28 , wherein said template is DNA.

30. The mixture of claim 28 , wherein said template is RNA.

31. The mixture of claim 28 , wherein said template is polyadenylated at its 3′ end, and wherein one of said primers contains poly-T.

32. The mixture of claim 28 , wherein said template, copy thereof, or complementary copy thereof has been extended to contain a 3′ sequence to which one of said primers can hybridize.

Assignments (3)
LIEN RELEASE Recorded Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 030182/0461 →
CHANGE OF NAME Recorded Jan 29, 2009
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 022162/0821 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: LIFE TECHNOLOGIES CORPORATION
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 021975/0467 →